ArticleCancer immunology, immunotherapy : CII2011
Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
Kevin Durgan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it